
Digital health funding and deals roundup: Bayer acquires AI platform company
Freenome, a biotech company, said it was working with Danville, Pennsylvania-based health system Geisinger, for a research effort that will pair multiomics with real-world data. Freenome’s platform uses machine learning technology to detect cancer at its earliest stages. The study will use both traditional and real-world data to generate evidence of cancer for certain high- and elevated-risk populations.
Teladoc is laying off 500 employees
Bayer, a Big Pharma company, is acquiring a strategic imaging AI platform, Blackford Analysis. The company said the acquisition is part of its strategy to improve Bayer’s position in digital medicine imaging. It follows a development and licensing agreement between the companies in 2020. As part of the deal, Blackford will continue to operate as an independent organization.
Cleveland Clinic, Palantir Technologies enter multiyear partnership
Arrive Health, a real-time benefits company, is acquiring a suite of patient engagement and automation technologies developed by UPMC Enterprises and the UPMC Pharmacy Network. The combination will allow providers to share more upfront pricing with patients. UPMC has been working on this technology for the past five years. As part of the deal, UPMC invested an undisclosed amount in Arrive Health.
Sputtered out: Digital health funding in 2022 by the numbers
More deals and funding rounds:
Knownwell, a weight-inclusive provider, raised a $4.5 million seed round.
Posterity Health, a digital male fertility treatment company, raised $7.5 million.
SocialBoat, a women-focused health and fitness app secured $200,000 in angel funding.
CareLineLive, a home care management software company, closed a funding round valued around $3.7 million.
Sleepagotchi, a mobile sleep app, secured a $3.5 million seed round.
Authenticx, a conversational healthcare intelligence platform, closed a $20 million Series B round.
PneumoWave, a remote patient monitoring company focused on respiratory health, closed a $9.2 million Series A round.
Breathe Well, a diabetes startup, raised $6 million.
Rx Redefined, a tech-enabled provider of medical supply services for group practices, raised $8 million in Series A funding.
If there is a digital health funding or M&A deal that we missed from this past week here, please email us.
Digital Health Business & Technology’s data team contributed to this roundup.
Arrive Health, a real-time benefits company, is acquiring a suite of patient engagement and automation technologies developed by UPMC Enterprises and the UPMC Pharmacy Network. The combination will allow providers to share more upfront pricing with patients. UPMC has been working on this technology for the past five years. As part of the deal, UPMC invested an undisclosed amount in Arrive Health.